Diagnostic Autonomic denied as duplicate or overlapping therapy by Cigna?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for diagnostic autonomic are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Diagnostic Autonomic
## Why Cigna Denies Diagnostic Autonomic Testing as Duplicate Therapy
Autonomic nervous system testing — which may include tests such as quantitative sudomotor axon reflex testing, heart rate variability analysis, tilt-table studies, or other physiological measures of autonomic function — is a specialized diagnostic service. Cigna's duplicate-therapy denial in this context means the claims system identified a prior autonomic test or a closely related neurological study billed within the same coverage period and flagged the new service as redundant. This denial is common when a patient has multiple providers, when testing spans a plan-year boundary, or when different components of an autonomic test battery are billed under codes that appear similar to an automated review system.
## Why This Denial Is Appealable
Individual tests in an autonomic evaluation measure different physiological pathways and answer different clinical questions. A tilt-table study does not duplicate a sweat-function test; a single prior nerve-conduction study does not satisfy the clinical purpose of a dedicated autonomic battery. If the prior test cited in the denial is genuinely different in scope or answered a different clinical question, the duplicate determination is factually incorrect and can be overturned.
## Federal Appeal Framework
- Cigna group health plans are typically subject to ERISA §503, which requires a full-and-fair review of every claim denial.
- ACA §2719 external review rights apply: after exhausting Cigna's internal appeal process, you may request external review by a CMS-accredited Independent Review Organization — generally within four months of the final internal denial.
- Expedited internal appeal (72-hour response) is available when the standard timeline would seriously jeopardize health.
- File the internal appeal within the deadline stated on the Explanation of Benefits — typically 180 days.
## Concrete Appeal Steps
1. Obtain the Explanation of Benefits and identify the specific prior claim Cigna is treating as equivalent to the denied test. 2. Request Cigna's clinical review policy for autonomic testing and identify how it defines "duplicate" in this context. 3. Obtain a letter from the ordering neurologist or specialist explaining why the prior test and the denied test are clinically distinct and what additional clinical information the new test would provide. 4. Compile the test reports for both the prior study and the proposed study and highlight the differences in methodology, clinical question, and physiological system assessed. 5. Submit the internal appeal with the provider letter, both test records, and a cover letter explaining the clinical distinction.
## Documentation Checklist
- Explanation of Benefits identifying the prior claim Cigna cited
- Report and interpretation of the prior test
- Ordering provider's medical-necessity letter distinguishing the two tests clinically
- Relevant clinical notes documenting the patient's diagnosis, symptoms, and the specific clinical question the new test will answer
- Cigna's coverage policy for autonomic testing (request in writing if not publicly available)
## Criteria-Mapping Structure
Obtain the full text of Cigna's coverage policy for diagnostic autonomic testing (available at cigna.com or by written request). For each requirement, map the corresponding chart fact. For the duplicate argument specifically, create a side-by-side comparison of the prior test and the proposed test showing the different methodology and clinical purpose. This comparison is the core of the appeal.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →